Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -463,927 | -326,847 | -223,723 | -95,020 | -402,266 |
| Depreciation Amortization | -22,859 | -15,968 | -14,356 | -7,900 | -24,604 |
| Accounts payable and accrued liabilities | 34,584 | 3,275 | -5,036 | 5,672 | 11,225 |
| Other Working Capital | -54,895 | -52,410 | -81,626 | -73,833 | 81,320 |
| Other Operating Activity | 54,470 | 50,724 | 44,223 | 11,957 | 37,535 |
| Operating Cash Flow | $-452,627 | $-341,226 | $-280,518 | $-159,124 | $-296,790 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,086,701 | -2,271,486 | -1,038,346 | -687,697 | -1,329,896 |
| PPE Investments | -22,427 | -18,406 | -13,459 | -5,678 | -16,062 |
| Sale Of Investment | 1,200,194 | 912,120 | 557,919 | 248,696 | 624,462 |
| Other Investing Activity | -96,732 | -70,726 | -37,593 | -6,394 | -51,815 |
| Investing Cash Flow | $-2,005,666 | $-1,448,498 | $-531,479 | $-451,073 | $-773,311 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,435,656 | 2,456,808 | 825,926 | 5,024 | 636,043 |
| Other Financing Activity | 12,852 | -13,207 | 102,638 | 813,172 | 3,770 |
| Financing Cash Flow | $2,448,508 | $2,443,601 | $928,564 | $818,196 | $639,813 |
| Exchange Rate Effect | 426 | -924 | 4,652 | 6,062 | -6,686 |
| Beginning Cash Position | 398,554 | 398,554 | 398,554 | 398,554 | 835,528 |
| End Cash Position | 389,195 | 1,051,507 | 519,773 | 612,615 | 398,554 |
| Net Cash Flow | $-9,359 | $652,953 | $121,219 | $214,061 | $-436,974 |
| Free Cash Flow | |||||
| Operating Cash Flow | -452,627 | -341,226 | -280,518 | -159,124 | -296,790 |
| Capital Expenditure | -22,427 | -18,406 | -13,459 | -5,678 | -16,062 |
| Free Cash Flow | -475,054 | -359,632 | -293,977 | -164,802 | -312,852 |